Clarion Clinics Receives Ethics Board Endorsement for the First Dedicated Psychedelic-Assisted Therapy Clinic in Australia
Highlights:
MELBOURNE, Australia and NEW YORK, Dec. 21, 2023 (GLOBE NEWSWIRE) — Incannex Healthcare Ltd (Nasdaq:IXHL) (‘Incannex’ or ‘the Company’) a pharmaceutical company developing proprietary medicinal cannabinoid products and psychedelic assisted psychotherapies for unmet needs is pleased to announce that it has received ethics board endorsement for psychedelic assisted therapy at its first clinic based in Melbourne, Australia, a city of approximately 5.2M people.
Related news for (IXHL)
- Today’s Top Performers: MoBot’s Market Review 09/23/25 03:00 PM
- Today’s Top Performers: MoBot’s Market Review 08/26/25 06:00 AM
- MoBot alert highlights: NASDAQ: IXHL, NASDAQ: HKPD, NASDAQ: PFSA, NASDAQ: IVVD, NASDAQ: BENF (08/26/25 05:00 AM)
- Power Hour Push: Biotech, Blockchain, and Breakouts Set to Run into Afterhours
- Today’s Top Performers: MoBot’s Market Review 08/22/25 09:00 AM